Sign in
4

Changes in Ownership

Amphastar Pharmaceuticals, Inc. Filed Acc 0001415889-25-008523

CEO & CHIEF SCIENTIFIC OFFICER gave up 426,195 shares (to pay taxes)

  • CEO & CHIEF SCIENTIFIC OFFICER acquired 501,690 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Zhang Jack Y. CEO & CHIEF SCIENTIFIC OFFICER 2025-03-14 Option exercise +290,477 $14.69 $4,267,107 2,899,859 D
Zhang Jack Y. CEO & CHIEF SCIENTIFIC OFFICER 2025-03-14 Shares withheld for taxes −226,285 $26.66 $6,032,758 2,673,574 D
Zhang Jack Y. CEO & CHIEF SCIENTIFIC OFFICER 2025-03-15 Shares withheld for taxes −9,765 $26.66 $260,335 2,663,809 D
Zhang Jack Y. CEO & CHIEF SCIENTIFIC OFFICER 2025-03-17 Shares withheld for taxes −16,150 $27.69 $447,194 2,647,659 D
Zhang Jack Y. CEO & CHIEF SCIENTIFIC OFFICER 2025-03-14 Option exercise +211,213 $14.69 $3,102,719 1,359,470 I
Zhang Jack Y. CEO & CHIEF SCIENTIFIC OFFICER 2025-03-14 Shares withheld for taxes −162,657 $26.66 $4,336,436 1,196,813 I
Zhang Jack Y. CEO & CHIEF SCIENTIFIC OFFICER 2025-03-15 Shares withheld for taxes −4,115 $26.66 $109,706 1,192,698 I
Zhang Jack Y. CEO & CHIEF SCIENTIFIC OFFICER 2025-03-17 Shares withheld for taxes −7,223 $27.69 $200,005 1,185,475 I
Derivatives
Zhang Jack Y. CEO & CHIEF SCIENTIFIC OFFICER 2025-03-14 Option exercise · Employee Stock Option (right to buy) −290,477 0 D
Zhang Jack Y. CEO & CHIEF SCIENTIFIC OFFICER 2025-03-14 Option exercise · Employee Stock Option (right to buy) −211,213 0 I
Loading xslF345X05/form4-03182025_110313.xml…